BD Board Approves Increased Dividend and Share Buyback Plan
BD Announces Quarterly Dividend and Share Repurchase Plans
BD (Becton, Dickinson and Company) (NYSE: BDX), a frontrunner in the global medical technology sector, has made significant announcements recently regarding its financial strategies. The company declared a quarterly dividend of $1.04 per common share, underscoring its commitment to providing value to its shareholders. This dividend will be paid on March 31 to those recorded as shareholders by March 10.
Financial Highlights and Share Repurchase Initiative
In addition to the dividend declaration, BD has also disclosed that it has successfully repurchased $750 million worth of its stock by the current fiscal year’s end. This initiative is part of a broader strategy to enhance shareholder value through share buybacks. Furthermore, the Board has authorized the repurchase of an additional 10 million shares, indicating the company’s bullish outlook on its own financial health.
Share Buyback Authorization Details
The newly approved buyback plan allows BD to purchase shares using various methods, including open-market transactions or privately negotiated deals. Management will decide the specifics of the repurchases, taking into account prevailing market conditions and the stock’s market price. This flexibility in execution is aimed at optimizing the timing and impact of these transactions on the stock value.
About BD: Leading the Way in Medical Technology
BD is recognized as one of the largest global medical technology firms, making strides in improving healthcare outcomes worldwide. With a dedicated workforce of over 70,000 employees, BD focuses on enhancing clinical therapy and process efficiency through innovative solutions. The company is dedicated to supporting healthcare professionals by providing advanced technology that helps combat global health challenges.
Commitment to Healthcare Improvement
The organization's core mission revolves around enhancing the safety and efficiency of healthcare delivery. BD works alongside laboratory scientists and researchers to accurately diagnose diseases and develop cutting-edge therapeutics. Their partnerships with various healthcare entities are aimed at addressing critical health concerns around the globe. By fostering such collaborations, BD is able to impact outcomes positively and increase access to effective healthcare solutions.
Contact Information for BD
For media inquiries, Troy Kirkpatrick is the primary contact person, serving as the VP of Public Relations. He can be reached at 858.617.2361. Adam Reiffe, the Senior Director of Investor Relations, is available for questions related to investor matters at 201.847.6927.
Frequently Asked Questions
What is the declared quarterly dividend amount by BD?
BD has declared a quarterly dividend of $1.04 per common share.
When will the dividend be paid to shareholders?
The dividend will be paid on March 31 to shareholders recorded by March 10.
How much has BD repurchased in stock during the fiscal year?
BD has repurchased a total of $750 million in stock to date in the current fiscal year.
What new share repurchase authorization has BD received?
BD's Board has authorized the repurchase of up to 10 million additional shares of its common stock.
Who can I contact for media inquiries regarding BD?
Troy Kirkpatrick is the main media contact at BD, reachable at 858.617.2361.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.